Gene · 7130
Papers2,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural insights into the biological functions of the long pentraxin PTX3. | Front Immunol | 2023 | 37885881 | PubTator, text mining | PubMed |
| Innovative preconditioning strategies for improving the therapeutic efficacy of extracellular vesicles derived from mesenchymal stem cells in gastrointestinal diseases. | Inflammopharmacology | 2023 | 37874430 | PubTator, text mining | PubMed |
| Human TIMP1 Is a Growth Factor That Improves Oocyte Developmental Competence. | BioTech (Basel) | 2023 | 37873882 | PubTator, text mining | PubMed |
| Unraveling The Effects of DICER1 Overexpression on Immune-Related Genes Expression in Mesenchymal Stromal/Stem Cells: Insights for Therapeutic Applications. | Cell J | 2023 | 37865878 | PubTator, text mining | PubMed |
| Transcriptome analysis reveals molecular signature and cell-type difference of Homo sapiens endothelial-to-mesenchymal transition. | G3 (Bethesda) | 2023 | 37857450 | PubTator, text mining | PubMed |
| Cumulus expansion is impaired with advanced reproductive age due to loss of matrix integrity and reduced hyaluronan. | Aging Cell | 2023 | 37850336 | PubTator, text mining | PubMed |
| New insights in application of mesenchymal stem cells therapy in tumor microenvironment: pros and cons. | Front Cell Dev Biol | 2023 | 37849741 | PubTator, text mining | PubMed |
| A comparison of rat models that best mimic immune-driven preeclampsia in humans. | Front Endocrinol (Lausanne) | 2023 | 37842294 | PubTator, text mining | PubMed |
| Where Are We and Where to Next?-The Future of Perianal Crohn's Disease Management. | J Clin Med | 2023 | 37835022 | PubTator, text mining | PubMed |
| MUC1-C intersects chronic inflammation with epigenetic reprogramming by regulating the set1a compass complex in cancer progression. | Commun Biol | 2023 | 37821650 | PubTator, text mining | PubMed |
| NAT10/ac4C/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer. | Adv Sci (Weinh) | 2023 | 37818745 | PubTator, text mining | PubMed |
| Monitoring regulatory T cells as a prognostic marker in lung transplantation. | Front Immunol | 2023 | 37818354 | PubTator, text mining | PubMed |
| Advances in stem cell therapy for peritoneal fibrosis: from mechanisms to therapeutics. | Stem Cell Res Ther | 2023 | 37817212 | PubTator, text mining | PubMed |
| Lymph Node Dissection in Upper Tract Urothelial Carcinoma: Current Status and Future Perspectives. | Curr Oncol Rep | 2023 | 37801187 | PubTator, text mining | PubMed |
| Fluid flow shear stress and tissue remodeling-an orthodontic perspective: evidence synthesis and differential gene expression network analysis. | Front Bioeng Biotechnol | 2023 | 37795174 | PubTator, text mining | PubMed |
| Human umbilical cord mesenchymal stem cells in diabetes mellitus and its complications: applications and research advances. | Int J Med Sci | 2023 | 37790847 | PubTator, text mining | PubMed |
| Multifaceted analysis of cross-tissue transcriptomes reveals phenotype-endotype associations in atopic dermatitis. | Nat Commun | 2023 | 37783685 | PubTator, text mining | PubMed |
| Premature senescence and cardiovascular disease following cancer treatments: mechanistic insights. | Front Cardiovasc Med | 2023 | 37781317 | PubTator, text mining | PubMed |
The Glycosaminoglycan Side Chains and Modular Core Proteins of Heparan Sulphate Proteoglycans and the Varied Ways They Provide Tissue Protection by Regulating Physiological Processes and Cellular Behaviour. | Int J Mol Sci | 2023 | 37762403 | PubTator, text mining | PubMed |
| Human osteoarthritic articular cartilage stem cells suppress osteoclasts and improve subchondral bone remodeling in experimental knee osteoarthritis partially by releasing TNFAIP3. | Stem Cell Res Ther | 2023 | 37752608 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7130/papers?page=13